$CARL

Bertolini Jeffrey sold $3K of CARL

Bertolini Jeffrey (Chief Operating Officer) sold 243 shares of CARLSMED, INC. (CARL) at $13.99 on 2026-09-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bertolini Jeffrey
Published Oct 1, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CARL
Neutral
high confidence
Mentioned
$CARL
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CARLNeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to move the stock materially.

02

Market read

A small insider sale with limited market impact; traders may note the transaction but no immediate action is warranted.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 2/10Novelty 2/10Timing: today

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$CARLNeutralHigh confidence
Context

COO Bertolini Jeffrey sold 243 shares for $13.99 each via a 10b5-1 plan, reducing his stake to 22,489 shares.

Expected impact

potential modest downward pressure as the market prices the insider sell.

Evidence & confidence

The transaction size is small relative to float and disclosed via a Form 4, typical of routine liquidity events.

Market effects

None significant; the sale does not affect the broader healthcare sector.

No regional impact; the filing is company‑specific.

Minimal global relevance.

Counterpoint

The sale could be interpreted as a lack of confidence, but the size is too small to signal material concerns.

Key entities

  • Bertolini Jeffrey

    Chief Operating Officer of Carlsmed, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CARLHigh

Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

CARLSMED, INC. (CARL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Carlsmed ® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance Second quarter 2026 revenue of $18.9 million, representing 57% growth year-over-year Full year 2026 revenue guidance raised to $74 million to $78 million CARLSBAD, CALIFORNIA, AUGUST 5, 2026 (G

$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).

$DOLELow

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $8.6M of DOLE (indirect holdings)

Pale Fire Capital SE purchased 648,356 indirectly-held shares of Dole plc (DOLE) at an average of $13.19 ($13.12–$13.39, $8.55M total) across 3 trades over 2026-10-20 to 2026-10-22. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).